早期对凯胺治疗自杀危机的反应在3个月后减少了自杀事件
Martin Pastre1,2, Raphael Chancel3, Manon Malestroit3
1IGF, University of Montpellier, CNRS-INSERM, Montpellier, France.
The Journal of clinical psychiatry
|August 6, 2025
概括
静脉注射胺快速降低了自杀念头和抑郁症. 对胺治疗的早期反应与三个月内自杀事件的风险显著降低有关,这支持其在预防自杀方面的作用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 静脉注射 (IV) 胺在减少自杀念头方面表现有前途.
- 静脉胺对实际自杀企图的影响需要进一步调查.
- 这项研究检查了胺对SI和自杀事件的现实影响.
研究的目的:
- 调查IV胺在7天后减少自杀念头 (SI) 的有效性.
- 评估IV胺对3个月后自杀事件 (自杀未遂或SI住院) 的影响.
- 探索早期SI反应与长期自杀事件风险之间的关系.
主要方法:
- 对100名法国成年患者进行了观察性回顾性研究,这些患者接受了自杀危机治疗.
- 患者在一周内接受了1-2次IV胺注射 (0.5毫克/公斤).
- 在基线和7天评估抑郁症状 (MADRS) 和SI严重程度 (C-SSRS);在3个月收集自杀事件数据.
主要成果:
- 在7天内,IV胺显著降低了抑郁症状 (P < .001) 和SI严重程度 (P < .001).
- 在早期SI反应的患者中,观察到3个月后自杀事件的几率降低了75% (P = .009).
- 61%的患者实现了SI反应 (≥50%降低了C-SSRS严重程度).
结论:
- 在IV胺后早期降低SI预测未来自杀事件的风险较低.
- 胺除了抗抑郁作用之外,还显示出独特的抗自杀性质.
- 这些发现支持IV胺在全面的自杀预防策略中的潜在作用.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:30Electroconvulsive Therapy
189
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
189